The New FDA: Product Development, Pricing and Beyond

What impact will the incoming Trump administration have on the 2017 health care and life sciences regulatory outlook? In this podcast, Washington, D.C.-based partners Tom Bulleit (health care) and Al Cacozza (life sciences) offer their perspectives on what might lie ahead.

What is RopesTalk?

Ropes & Gray attorneys provide timely analysis on legal developments, court decisions and changes in legislation and regulations.